We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Issues New Draft Guidance on Identification of Suspect Products and Notification

13 June 2014

Pharmaceutical and Biotechnology Alert

On 11 June 2014, the FDA announced the availability of a draft guidance titled "Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification."

Read More: FDA Issues New Draft Guidance on Identification of Suspect Products and Notification

The team

Loading data